These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 35078345

  • 1. Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Matsuura D, Yuan A, Wang L, Ranganath R, Adilbay D, Harries V, Patel S, Tuttle M, Xu B, Ghossein R, Ganly I.
    Thyroid; 2022 Mar; 32(3):245-254. PubMed ID: 35078345
    [Abstract] [Full Text] [Related]

  • 2. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
    Jin M, Kim ES, Kim BH, Kim HK, Yi HS, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG.
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):618-627. PubMed ID: 32981304
    [Abstract] [Full Text] [Related]

  • 3. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
    Kim WG, Kim TY, Kim TH, Jang HW, Jo YS, Park YJ, Kim SW, Kim WB, Shong M, Park DJ, Chung JH, Shong YK, Cho BY.
    Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067
    [Abstract] [Full Text] [Related]

  • 4. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.
    Xu B, Wang L, Tuttle RM, Ganly I, Ghossein R.
    Hum Pathol; 2015 Dec; 46(12):1789-98. PubMed ID: 26482605
    [Abstract] [Full Text] [Related]

  • 5. Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
    Park H, Shin HC, Yang H, Heo J, Ki CS, Kim HS, Kim JH, Hahn SY, Chung YJ, Kim SW, Chung JH, Oh YL, Kim TH.
    Mod Pathol; 2022 Feb; 35(2):186-192. PubMed ID: 34497362
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma.
    Ernaga Lorea A, Migueliz Bermejo I, Anda Apiñániz E, Pineda Arribas J, Toni García M, Martínez de Esteban JP, Insausti Serrano AM.
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):136-142. PubMed ID: 29433918
    [Abstract] [Full Text] [Related]

  • 7. Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC.
    Li G, Ye Z, Wei T, Zhu J, Li Z, Lei J.
    J Clin Endocrinol Metab; 2024 Aug 13; 109(9):2294-2305. PubMed ID: 38436929
    [Abstract] [Full Text] [Related]

  • 8. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, Hoffmann M, Niederle B.
    Ann Surg; 2009 Jun 13; 249(6):1023-31. PubMed ID: 19474675
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
    Wenter V, Albert NL, Unterrainer M, Ahmaddy F, Ilhan H, Jellinek A, Knösel T, Bartenstein P, Spitzweg C, Lehner S, Todica A.
    Eur J Nucl Med Mol Imaging; 2021 Feb 13; 48(2):449-460. PubMed ID: 32683470
    [Abstract] [Full Text] [Related]

  • 10. Follicular thyroid carcinoma: histology and prognosis.
    D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH.
    Cancer; 2004 Mar 15; 100(6):1123-9. PubMed ID: 15022277
    [Abstract] [Full Text] [Related]

  • 11. Encapsulated Angioinvasive Follicular Thyroid Carcinoma: Prognostic Impact of the Extent of Vascular Invasion.
    Yamazaki H, Katoh R, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames KY, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Rino Y, Ito K.
    Ann Surg Oncol; 2022 Feb 15. PubMed ID: 35169976
    [Abstract] [Full Text] [Related]

  • 12. Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma.
    Kim HJ, Sung JY, Oh YL, Kim JH, Son YI, Min YK, Kim SW, Chung JH.
    Head Neck; 2014 Dec 15; 36(12):1695-700. PubMed ID: 24115217
    [Abstract] [Full Text] [Related]

  • 13. Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation.
    Kim MK, Park H, Oh YL, Shin JH, Kim TH, Hahn SY.
    Korean J Radiol; 2024 Jan 15; 25(1):103-112. PubMed ID: 38184773
    [Abstract] [Full Text] [Related]

  • 14. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY, Chan WF, Lam KY, Wan KY.
    Ann Surg; 2005 Nov 15; 242(5):708-15. PubMed ID: 16244545
    [Abstract] [Full Text] [Related]

  • 15. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA.
    Endocr Pathol; 2015 May 15; 26(2):164-9. PubMed ID: 25898815
    [Abstract] [Full Text] [Related]

  • 16. Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.
    Stegenga MT, Oudijk L, van Velsen EFS, Peeters RP, Medici M, Verburg FA, van Ginhoven TM, van Kemenade FJ, Visser WE.
    J Clin Endocrinol Metab; 2024 Aug 21. PubMed ID: 39166490
    [Abstract] [Full Text] [Related]

  • 17. Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis.
    Jikuzono T, Ishikawa T, Hirokawa M, Sugitani I, Ishibashi O.
    BMC Res Notes; 2020 May 13; 13(1):241. PubMed ID: 32404135
    [Abstract] [Full Text] [Related]

  • 18. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
    Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K.
    Thyroid; 2012 Aug 13; 22(8):798-804. PubMed ID: 22853727
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid.
    Ito Y, Hirokawa M, Fujishima M, Masuoka H, Higashiyama T, Kihara M, Onoda N, Miya A, Miyauchi A.
    Endocr J; 2021 Aug 28; 68(8):881-888. PubMed ID: 33746136
    [Abstract] [Full Text] [Related]

  • 20. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW.
    Diagn Cytopathol; 2006 May 28; 34(5):330-4. PubMed ID: 16604553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.